Official Title
Augmented Cognitive Behavioural Group Therapy for Perinatal Anxiety During a Global Pandemic (COVID-19)
Brief Summary

This study will evaluate the effectiveness of an augmented version of our current evidence-based Cognitive Behavioural Group Therapy (CBGT) for perinatal anxiety protocol with cognitive and behavioural strategies composed of critical COVID-related anxiety, worry, and impact content.

Completed
Perinatal Anxiety
COVID19

Other: Cognitive Behavioural Group Therapy for Perinatal Anxiety

The treatment consists of cognitive and behavioural strategies for treating anxiety, tailored specifically to a perinatal/postpartum population. Additional strategies for COVID-19 specific worry content have been included.

Eligibility Criteria

Inclusion Criteria:

- Females, aged 18-45 years

- Pregnant or up to six months postpartum

- Primary diagnosis of an anxiety disorder, as per the MINI for DSM-5, with or without
comorbid depression

- No concurrent psychological treatment

- Not taking psychoactive medication or medication is stable in dose and type for at
least 8 weeks prior to the study (as per Canadian Psychiatric Guidelines) and
throughout study duration (participants will not be excluded from treatment if
medication/dose changes during the study duration, however, they must notify the study
team immediately)

- Fluent in English in order to understand the consent and group material

Exclusion Criteria:

- Severe depression/suicidality

- Primary diagnosis other than an anxiety disorder

- Psychotic or current substance/alcohol use disorder

Eligibility Gender
Female
Eligibility Age
Minimum: 18 Years ~ Maximum: 45 Years
Countries
Canada
Locations

St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada

St. Joseph's Healthcare Hamilton
NCT Number
MeSH Terms
COVID-19
Anxiety Disorders